Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges of Sarcoidosis and Its Management
Marjolein Drent, Elliott D. Crouser, Johan Grünewald
New England Journal of Medicine (2021) Vol. 385, Iss. 11, pp. 1018-1032
Closed Access | Times Cited: 275

Showing 1-25 of 275 citing articles:

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
Jukka Lehtonen, Valtteri Uusitalo, Pauli Pöyhönen, et al.
European Heart Journal (2023) Vol. 44, Iss. 17, pp. 1495-1510
Open Access | Times Cited: 109
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
William Damsky, Alice Wang, Daniel Kim, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 79
Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation
Thomas Krausgruber, Anna Redl, Daniele Barreca, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 289-306.e7
Open Access | Times Cited: 71
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association
Richard K. Cheng, M. Kittleson, Craig J. Beavers, et al.
Circulation (2024) Vol. 149, Iss. 21
Closed Access | Times Cited: 49
Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial
Anna Redl, Konstantin Doberer, Luisa Unterluggauer, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 2, pp. e81-e91
Closed Access | Times Cited: 21
Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases
Yuming Sun, Qian Zhou, Lorraine Edna Onzere, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 1, pp. 103186-103186
Closed Access | Times Cited: 3
Comorbidities of sarcoidosis
Claudio Tana, Marjolein Drent, Hilario Nunès, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1014-1035
Open Access | Times Cited: 42
Cutaneous Sarcoidosis
Nnenna Ezeh, Avrom S. Caplan, Misha Rosenbach, et al.
Dermatologic Clinics (2023) Vol. 41, Iss. 3, pp. 455-470
Closed Access | Times Cited: 26
Management of cardiac sarcoidosis
Rakesh Sharma, Vasileios Kouranos, Leslie T. Cooper, et al.
European Heart Journal (2024) Vol. 45, Iss. 30, pp. 2697-2726
Open Access | Times Cited: 15
Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies
Samuel Jaimez-Alvarado, Itzel Ivonn López-Tenorio, Javier Santos, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 144-144
Open Access | Times Cited: 1
Shifting temporal trends and disparities in sarcoidosis mortality in the United States: A retrospective analysis from 1999 to 2020
Fatima Ali Raza, Sumeet Kumar, Ayesha Mohammad, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317237-e0317237
Open Access | Times Cited: 1
Upregulation of HSP90α in the lungs and circulation in sarcoidosis
Takuma Isshiki, Motoko Sunakawa, Megan Vierhout, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 1
Insights Into Hepatic Sarcoidosis: Analysis of Histological Patterns, Hepatic Complications and Therapeutic Approaches
Ludwig J. Horst, Katharina Zimmermann, Johanna Lutz, et al.
Liver International (2025) Vol. 45, Iss. 3
Open Access | Times Cited: 1
GWAS identifies genetic loci, lifestyle factors and circulating biomarkers that are risk factors for sarcoidosis
Shuai Yuan, Jie Chen, Jiawei Geng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate
Vivienne Kahlmann, Montse Janssen Bonás, Catharina C. Moor, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 1
Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches
Ogugua Ndili, Lesley Ann Saketkoo, Anne‐Marie Russell, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 32
Hit-hard and early versus step-up treatment in severe sarcoidosis
Adriane D.M. Vorselaars, Daniel A. Culver
Current Opinion in Pulmonary Medicine (2022) Vol. 28, Iss. 5, pp. 461-467
Open Access | Times Cited: 30
Aberrant Lipid Metabolism in Macrophages Is Associated with Granuloma Formation in Sarcoidosis
Clarice X. Lim, Anna Redl, Lisa Kleißl, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 9, pp. 1152-1164
Closed Access | Times Cited: 8
Update on cardiac sarcoidosis
Jian Liang Tan, Bryan E‐Xin Tan, Jim W. Cheung, et al.
Trends in Cardiovascular Medicine (2022) Vol. 33, Iss. 7, pp. 442-455
Closed Access | Times Cited: 26
Cutibacterium Acnes (Formerly Propionibacterium Acnes ): Friend or Foe?
Lyudmila Boyanova
Future Microbiology (2023) Vol. 18, Iss. 4, pp. 235-244
Closed Access | Times Cited: 15
Diagnosis and Treatment of Cardiac Sarcoidosis
Alessandro De Bortoli, David H. Birnie
Circulation Journal (2023) Vol. 87, Iss. 4, pp. 471-480
Open Access | Times Cited: 14
Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis
Laura Ueberham, Andreas Hagendorff, Karin Klingel, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 6
Open Access | Times Cited: 14
Current developments and opportunities of pluripotent stem cells-based therapies for salivary gland hypofunction
Wenpeng Song, Huan Liu, Yingying Su, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Clinical Characteristics and Mechanisms of Acute Myocarditis
Stéphane Heymans, Sophie Van Linthout, Sarah Kraus, et al.
Circulation Research (2024) Vol. 135, Iss. 2, pp. 397-411
Closed Access | Times Cited: 6
Sarcoidosis and lymphoma mortality risk: An observational study from the Spanish National Registry
Víctor Moreno‐Torres, María Martínez‐Urbistondo, Pedro Durán‐del Campo, et al.
Journal of Translational Autoimmunity (2024) Vol. 8, pp. 100236-100236
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top